Sharp Therapeutics Corp. (TSXV:SHRX)

Canada flag Canada · Delayed Price · Currency is CAD
1.850
0.00 (0.00%)
At close: Apr 30, 2025
-15.91%
Market Cap 55.39M
Revenue (ttm) n/a
Net Income (ttm) -4.69M
Shares Out 29.94M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 200
Average Volume 2,837
Open 1.850
Previous Close 1.850
Day's Range 1.850 - 1.850
52-Week Range 1.800 - 2.280
Beta n/a
RSI 46.91
Earnings Date n/a

About Sharp Therapeutics

Sharp Therapeutics Corp., a biology technology company, develops medicines specific for genetic diseases. It engages in the development of the CoreX biology, AlloChem chemistry, and Disco/Mine computational technologies to discover drugs that activate the protein altered by gene mutation. Sharp Therapeutics Corp. is based in Pittsburgh, Pennsylvania. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Scott Sneddon
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol SHRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.